Sean Maenpaa Email

VP - Urologic Oncology Commercialization . Telix Pharmaceuticals Limited

Current Roles

Employees:
447
Revenue:
$69.3M
About
Telix is a biopharmaceutical company focused on the development of diagnostic and therapeutic products using Molecularly Targeted Radiation (MTR). Telix is headquartered in Melbourne, Australia with international operations in Belgium, Japan, and the United States. Telix is developing a portfolio of clinical-stage products that address significant unmet medical need in oncology and rare diseases. Telix is listed on the Australian Securities Exchange (ASX: TLX).
Telix Pharmaceuticals Limited Address
55 Flemington Rd
North Melbourne, null
Australia
Telix Pharmaceuticals Limited Email
Telix Pharmaceuticals Limited Phone Numbers
+61 3 9347 9558

Past Companies

Telix Pharmaceuticals LimitedVice President - Urologic Oncology Commercialization
Clovis OncologyHead of Business Development and Targeted Radionuclide Therapy Portfolio Commericalization
Clovis OncologyExecutive Director, New Product Commercialization

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.